Works matching IS 03407004 AND DT 2010 AND VI 59 AND IP 5
Results: 16
Activation of innate immunity to reduce lung metastases in breast cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 789, doi. 10.1007/s00262-009-0800-x
- By:
- Publication type:
- Article
Naturally occurring systemic immune responses to HPV antigens do not predict regression of CIN2/3.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 799, doi. 10.1007/s00262-009-0806-4
- By:
- Publication type:
- Article
Comparison of AAV/IL-7 autocrine (T cell) versus paracrine (DC) gene delivery for enhancing CTL stimulation and function.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 779, doi. 10.1007/s00262-009-0798-0
- By:
- Publication type:
- Article
Immunogenic chemotherapy with cyclophosphamide and doxorubicin against established murine carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 769, doi. 10.1007/s00262-009-0797-1
- By:
- Publication type:
- Article
Ten-year survival analysis for renal carcinoma patients treated with an autologous tumour lysate vaccine in an adjuvant setting.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 687, doi. 10.1007/s00262-009-0784-6
- By:
- Publication type:
- Article
Initial characterization of an immunotoxin constructed from domains II and III of cholera exotoxin.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 737, doi. 10.1007/s00262-009-0794-4
- By:
- Publication type:
- Article
Nuclear factor kappaB-activated monocytes contribute to pancreatic cancer progression through the production of Shh.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 675, doi. 10.1007/s00262-009-0783-7
- By:
- Publication type:
- Article
Intratumoral CD8<sup>+</sup> T/FOXP3<sup>+</sup> cell ratio is a predictive marker for survival in patients with colorectal cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 653, doi. 10.1007/s00262-009-0781-9
- By:
- Publication type:
- Article
Immunologic and Prognostic Factors Associated with Overall Survival Employing a Poxviral-based PSA Vaccine in Metastatic Castrate-resistant Prostate Cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 1, doi. 10.1007/s00262-009-0782-8
- By:
- Publication type:
- Article
Testing the theory of immune selection in cancers that break the rules of transplantation.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 643, doi. 10.1007/s00262-009-0809-1
- By:
- Publication type:
- Article
EphA2-derived peptide vaccine with amphiphilic poly(γ-glutamic acid) nanoparticles elicits an anti-tumor effect against mouse liver tumor.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 759, doi. 10.1007/s00262-009-0796-2
- By:
- Publication type:
- Article
Generation of antigen-presenting cells from tumor-infiltrated CD11b myeloid cells with DNA demethylating agent 5-aza-2′-deoxycytidine.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 697, doi. 10.1007/s00262-009-0786-4
- By:
- Publication type:
- Article
Identification and characterization of a HER-2/ neu epitope as a potential target for cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 715, doi. 10.1007/s00262-009-0791-7
- By:
- Publication type:
- Article
A persistent virus vector confers superior anti-tumor immunity, compared with a non-persistent vector.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 707, doi. 10.1007/s00262-009-0790-8
- By:
- Publication type:
- Article
TNF-alpha-treated DC exacerbates disease in a murine tumor metastasis model.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 729, doi. 10.1007/s00262-009-0793-5
- By:
- Publication type:
- Article
Topoisomerase II alpha as a universal tumor antigen: antitumor immunity in murine tumor models and H-2K<sup>b</sup>-restricted T cell epitope.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 747, doi. 10.1007/s00262-009-0795-3
- By:
- Publication type:
- Article